Form D · Biotechnology
GENHEALTH, INC.
Vienna, VA · CIK 0001980883
Offering snapshot reported Sep 29, 2026 · SEC filing
- Reported sold
- $16.5M Offering amount: $16.5M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 4, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 29, 2026 | Initial | $16,499,983 | No comparison | 8 | SEC filing |
| Jun 9, 2023 | Initial | $12,999,995 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-599171
Source: Form D, filed Sep 29, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Victor Lanio | Director |
| Eric Marriott | Director, Executive |
| Ritwik Sahu | Director, Executive |
| Kahini Shah | Director |
| Ethan Siegel | Director |
| Vishal Vasishth | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
520 Lewis St Nw
Vienna, VA, 22180
Phone: (786) 351-0609
Vienna, VA, 22180
Phone: (786) 351-0609